FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Actavis Pharmaceuticals buPROPion Hydrochloride Extended Recall

buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only

Actavis Pharmaceuticals · Morristown, NJ

Risk level
Class III
Reported by FDA
Mar 6, 2013
Recall ID
D-175-2013
Check your lot numberHow we source this data

Summary

Actavis Pharmaceuticals recalled buPROPion Hydrochloride Extended starting Jan 4, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-175-2013 on Mar 6, 2013. Reason: Failed Dissolution Specifications; 8-hours for the 18-month stability testing point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.

Product description

buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217

Lot numbers, UPCs & expiration codes

Lot CB1D05A,

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-175-2013
Classification
Class III
Status
Terminated
Recall initiated
Jan 4, 2013
FDA report date
Mar 6, 2013
Quantity
14,856 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-175-2013, exactly as published.

Show all FDA fields
City
Morristown
State
NJ
Status
Terminated
Country
United States
Event ID
64317
Address
60 Columbia Rd Bldg B
Code information
Lot CB1D05A,
Postal code
07960-4535
Report date
Mar 6, 2013
Product type
Drugs
Recall number
D-175-2013
Classification
Class III
Recalling firm
Actavis Pharmaceuticals
Product quantity
14,856 bottles
Termination date
Jan 13, 2014
Reason for recall
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
Distribution pattern
Nationwide
Recall initiation date
Jan 4, 2013
Initial firm notification
Letter
Center classification date
Feb 27, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-175-2013, published Mar 6, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls